Table 1.

Patient and tumor characteristics

Parameter	IDH-mutant astrocytoma	IDH wild-type astrocytoma	Oligodendroglioma
Total number	16	24	16
Progress	5	11	2
PFS rate	0.69	0.54	0.88
Mean patient age	40.3 ± 14.7	53.8 ± 17.3	46.2 ± 14.1
Patient sex (male/female)	10 / 6	15 / 9	8 / 8
Complete resection	4	2	7
Radiotherapy	10	20	10
Chemotherapy	7	19	10
WHO grade II	11	5	13
WHO grade III	3	14	3
WHO grade IV	2	5	-

IDH isocitrate dehydrogenase, n number, PFS rate progression-free survival rate after 1 year, WHO World Health Organization